Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $3.1850 (7.24%) ($3.1850 - $3.1850) on Wed. Aug. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.72% (three month average) | RSI | 28 | Latest Price | $3.1850(7.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -10.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) SPLV(45%) EWP(44%) LIT(44%) XBI(44%) XLU(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.86% in a week (0% probabilities). XOP(5%) CEMB(6%) EDOC(7%) BNDX(7%) XRT(8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.86% (StdDev 9.72%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-87.38(-2843.49%) | Resistance Level | $4.29 | 5 Day Moving Average | $3.04(4.77%) | 10 Day Moving Average | $3.16(0.79%) | 20 Day Moving Average | $4.29(-25.76%) | To recent high | -63.7% | To recent low | 11.6% | Market Cap | $237m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |